August 6, 2024
We are proud to announce that Mana.bio has been recognized by TheMarker as one of the Top 20 most promising startups in Israel. This recognition places us alongside other innovative companies, showcasing the vibrant and resilient startup community in Israel.
TheMarker's acknowledgment highlights our pioneering work in lipid nanoparticle (LNP) technology, a crucial platform for targeted RNA delivery. Our commitment to combining AI sets us apart in the quest to develop innovative therapeutic solutions.
This recognition is not just an honor for our team, but also a testament to the incredible potential within our community. As we continue to bring exciting ideas to life, we are grateful for the support and recognition from such a prestigious publication.
To learn more, you can read the full article on TheMarker here.